In a preclinical study, researchers at Children's Hospital of Philadelphia (CHOP) demonstrated a novel gene therapy with ...
A preclinical study by HSS investigators found that earlier anterior cruciate ligament (ACL) reconstruction led to lower ...
These preclinical studies mark a step forward in evaluating Polyrizon’s Trap and Target™ (T&T) platform for the intranasal administration of Naloxone, an opioid antagonist designed to rapidly ...
Polyrizon Ltd., a biotech company based in Raanana, Israel, has announced the start of preclinical studies for its intranasal Naloxone product aimed at treating opioid overdoses. Collaborating ...
MIRA Pharmaceuticals unveils Ketamir-2 topical for neuropathic pain, complementing its oral version. Clinical and preclinical ...
This collaboration will involve implementing the Aiforia ® Studies module within Orion's preclinical histology processes, as well as joint development to further automate and improve the study ...
Polyrizon Ltd. (Nasdaq: PLRZ) (the 'Company' or 'Polyrizon'), a development stage biotech company specializing in the development of innovative intranasal hydrogels, announced today the initiation of ...